Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
207 Leser
Artikel bewerten:
(0)

Portuguese Hospital Expands its VNA From Sectra With Digital Pathology to Improve Cancer Care

LINKÖPING, Sweden, June 19, 2018 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a digital pathology contract with Instituto Português de Oncologia de Lisboa (IPO Lisboa). IPO Lisboa is renowned for its cancer care and is the first hospital in Portugal to seamlessly include digital pathology in its existing VNA. The solution allows pathologists to access images from any workstation within the hospital as well as remotely, and enables integrated diagnostic workflows-especially important for improving cancer care.

"Sectra's digital pathology solution gives us access to already-proven calculation algorithms that will translate into greater reproducibility of results and have an impact on clinical decisions," says Dr. José Cabeçadas, Pathology Manager, Instituto Português de Oncologia de Lisboa.

IPO Lisboa is expanding its medical imaging IT solution for radiology to also include pathology. The solution will provide pathologists with instant access to images and related data, digital tools for reviewing the images and the ability to collaborate across both departments and locations.

"The use of a single system for the entire hospital guarantees a universal availability of resources and the possibility to work remotely," continues Dr. Cabeçadas. "An immediate additional benefit is that the solution will provide increased efficiency in the preparations for multidisciplinary meetings."

Sectra's digital pathology solution

Sectra's digital pathology solution includes digital tools which enable the pathologists to make their diagnoses and carry out reporting with higher precision and less time spent per case. It is a complete, vendor-neutral solution for primary diagnostics that includes storage solutions and an advanced review workstation.

Sectra's pathology solution is part of Sectra's Enterprise Image Management (EIM) solution. Sectra's enterprise imaging portfolio provides a unified strategy for all imaging needs, and improves patient outcomes while lowering operational costs. The scalable and modular solution supports the most image-intense departments-radiology, breast imaging, pathology, cardiology and orthopaedics. Being built on the same technical platform, customers can easily extend a departmental solution to create a comprehensive VNA. Read more about Sectra Enterprise Image Management and why Sectra PACS is "Best in KLAS" at https://www.sectra.com/medical/.

For further information, please contact:

Dr. Torbjörn Kronander
CEO and President Sectra AB
+46 (0)705-23-52-27

Marie Ekström Trägårdh
Executive Vice President Sectra AB and President Sectra Imaging IT Solutions
+46 (0)708-23-56-10

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/sectra/r/portuguese-hospital-expands-its-vna-from-sectra-with-digital-pathology-to-improve-cancer-care,c2551292

The following files are available for download:

http://news.cision.com/sectra/i/portuguese-hospital-expands-its-vna-from-sectra-with-digital-pathology-to-improve-cancer-care,c2435382

Portuguese hospital expands its VNA from Sectra with digital pathology to improve cancer care

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2018 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.